Trial Profile
A cohort study to evaluate the relationship between phasing out stavudine in first-line antiretroviral therapy and single-drug substitutions in sub-Saharan Africa: IeDEA-Multiregional Database
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs Stavudine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 12 Nov 2016 New trial record
- 20 Oct 2016 Results published in the AIDS